peak glp 1 GLP-1 Program Peaka GLP-1 Review: Real Skimming

Whether its deciding between Ozempic and Mounjaro for their dosing frequency and efficacy in managing Type 2 diabetes or comparing Wegovy and Zepbound for their main FDA-approved use in weight loss, patients and healthcare providers now have a comprehensive guide to navigate these decisions

Healthcare providers should discuss this likelihood during shared decision-making conversations, along with considerations of cost, insurance coverage, medication availability, and perioperative management (as these agents delay gastric emptying)

PMID: 42070571

Conclusion The effects of GLP-1 RAs on HF surrogate endpoints vary in HF patients across the LVEF spectrum

GBD 2021 Diabetes Collaborators